Frontlight ResearchEarly access
Taking peopleNo phase
Efficacy of Add-on Plasma Exchange As an Adjunctive Strategy Against Septic Shock
Key facts
- Who runs it
- Hannover Medical School
- Where
- Austria, Germany, and Switzerland25 sites in 3 countriesChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 274 people, planned
- Started
- 19 Feb 2025
- Expected to end
- Apr 2028
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Therapeutic Plasma Exchange (TPE)
- Record updated
- 13 March 2025
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- New onset of septic shock (< 24 hrs), (SEPSIS-3 definition)
- Norepinephrine (NE) dose ≥ 0.4 μg/kg/min ≥ 30 min OR NE ≥ 0.3 μg/kg/min + vasopressin (any dose)
- Established vascular access suitable for plasma exchange independent of study inclusion (due to established indication of RRT, expected need for RRT within the next 48 hours or other medical reasons as assessed by treating physician team)
Who cannot take part
- Urogenital focus of infection
- Age < 18 or > 80 years
- Pregnancy
- Heparin-induced thrombocytopenia
- Known reaction against fresh frozen plasma (FFP)
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
This trial has no sites in United States.
It has sites in 3 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
Randomized, prospective, multicenter, open-label, controlled, parallel-group interventional trial to test the adjunctive effect of therapeutic plasma exchange in patients with early septic shock.
The 2 groups in the trial
- Therapeutic Plasma Exchange (TPE)Treatment being tested
1 x TPE with donor Fresh Frozen Plasma (FFPs) (1.2 x individual plasma volume) within the first 6 hrs after randomization. A second TPE can be performed if the patient remains vasopressor dependent ≥ 0.4 ug/kg/min within 24 hours after the first intervention.
- Standard of Care (SOC)No study treatment, for comparison
Non-interventional standard of care
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Randomized, Prospective, Multicenter, Open-label, Controlled, Parallel-group Trial Investigating the Efficacy of Add-on Plasma Exchange As an Adjunctive Strategy Against Septic Shock - 2
- Criteria questions
- Built from NCT05726825, who can take part
- Publications
- Record updated
- 13 March 2025